Fig. 4From: A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerTMB and somatic mutations between the low- and high-risk groups. A The TMB analysis reveals high TMB in the low-risk group versus the high-risk group. B The Kaplan-Meier survival analysis shows longer overall survival of high-TMB patients compared to low-TMB patients. C Somatic mutations in the high versus low-risk groups. D List of somatic mutations in the low-risk groupBack to article page